A narrative review on the role of gut microbiome, dietary strategies, and supplements in managing metabolic syndrome

Abstract

Metabolic syndrome is a complex, multifactorial disorder, with emerging research emphasizing the significant role of gut health in its prevention and management. Recent studies suggest that dietary strategies promoting a healthy gut microbiome, including the incorporation of fiber, fermented foods, and healthy fats, are crucial for regulating metabolism. Additionally, the use of postbiotics and supplements, such as probiotics, omega-3 fatty acids, and polyphenols, provides promising avenues for enhancing metabolic health. This holistic approach to managing metabolic syndrome not only supports gut health but also offers the potential for improving long-term health outcomes. This review examines the influence of the gut microbiome on metabolism, highlighting the increasing significance of dietary strategies and supplements in managing metabolic syndrome.

Keywords

Metabolic syndrome / healthy gut microbiome / probiotics / omega-3 fatty acid / dietary strategies

References

[1] Castro—Barquero S, Ruiz—León AM, Sierra—Pérez M, Estruch R, Casas R. Dietary Strategies for Metabolic Syndrome: A Comprehensive Review. Nutrients. 2020; 12: 2983.

[2] Andersen CJ, Fernandez ML. Dietary strategies to reduce metabolic syndrome. Rev Endocr Metab Disord. 2013; 14: 241-54.

[3] Croci S, D’Apolito LI, Gasperi V, Catani MV, Savini I. Dietary Strategies for Management of Metabolic Syndrome: Role of Gut Microbiota Metabolites. Nutrients. 2021; 13: 1389.

[4] Ambroselli D, Masciulli F, Romano E, Catanzaro G, Besharat ZM, Massari MC, et al. New Advances in Metabolic Syndrome, from Prevention to Treatment: The Role of Diet and Food. Nutrients. 2023; 15: 640.

[5] Marrone G, Guerriero C, Palazzetti D, Lido P, Marolla A, Di Daniele F, et al. Vegan Diet Health Benefits in Metabolic Syndrome. Nutrients. 2021; 13: 817.

[6] Mohamed SM, Shalaby MA, El—Shiekh RA, El—Banna HA, Emam SR, Bakr AF. Metabolic syndrome: risk factors, diagnosis, pathogenesis, and management with natural approaches. Food Chem Adv. 2023; 3: 100335.

[7] Wang PX, Deng XR, Zhang CH, Yuan HJ. Gut microbiota and metabolic syndrome. Chin Med J (Engl). 2020; 133: 808—16.

[8] Netto Candido TL, Bressan J, Alfenas RCG. Dysbiosis and metabolic endotoxemia induced by high—fat diet. Nutr Hosp. 2018; 35: 1432-40.

[9] Alhabeeb H, AlFaiz A, Kutbi E, AlShahrani D, Alsuhail A, AlRajhi S, et al. Gut Hormones in Health and Obesity: The Upcoming Role of Short Chain Fatty Acids. Nutrients. 2021; 13: 481.

[10] O’Riordan KJ, Collins MK, Moloney GM, Knox EG, Aburto MR, Fülling C, et al. Short chain fatty acids: Microbial metabolites for gut—brain axis signalling. Mol Cell Endocrinol. 2022; 546: 111572.

[11] Dabke K, Hendrick G, Devkota S. The gut microbiome and metabolic syndrome. J Clin Invest. 2019; 129: 4050-7.

[12] Mazidi M, Rezaie P, Kengne AP, Mobarhan MG, Ferns GA. Gut microbiome and metabolic syndrome. Diabetes Metab Syndr Clin Res Rev. 2016; 10: S150—7.

[13] Yumuk V, Tsigos C, Fried M, Schindler K, Busetto L, Micic D, et al. ; Obesity Management Task Force of the European Association for the Study of Obesity. European Guidelines for Obesity Management in Adults. Obes Facts. 2015; 8: 402-24.

[14] Yaghmaei H, Bahanesteh A, Soltanipur M, Takaloo S, Rezaei M, Siadat SD. The Role of Gut Microbiota Modification in Nonalcoholic Fatty Liver Disease Treatment Strategies. Int J Hepatol. 2024; 2024: 4183880.

[15] Dong K, Zheng Y, Wang Y, Guo Q. Predictive role of neutrophil percentage—to—albumin ratio, neutrophil—to—lymphocyte ratio, and systemic immune—inflammation index for mortality in patients with MASLD. Sci Rep. 2024; 14: 30403.

[16] Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A. Gut microbiota and metabolic syndrome. World J Gastroenterol. 2014; 20: 16079—94.

[17] Alou MT, Lagier JC, Raoult D. Diet influence on the gut microbiota and dysbiosis related to nutritional disorders. Hum Microbiome J. 2016; 1: 3-11.

[18] Amabebe E, Robert FO, Agbalalah T, Orubu ESF. Microbial dysbiosis—induced obesity: role of gut microbiota in homoeostasis of energy metabolism. Br J Nutr. 2020; 123: 1127—37.

[19] Saad MJ, Santos A, Prada PO. Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance. Physiology (Bethesda). 2016; 31: 283-93.

[20] Visekruna A, Luu M. The Role of Short—Chain Fatty Acids and Bile Acids in Intestinal and Liver Function, Inflammation, and Carcinogenesis. Front Cell Dev Biol. 2021; 9: 703218.

[21] Mozaffarian D, Wu JHY. Flavonoids, Dairy Foods, and Cardiovascular and Metabolic Health: A Review of Emerging Biologic Pathways. Circ Res. 2018; 122: 369-84.

[22] Schoeler M, Caesar R. Dietary lipids, gut microbiota and lipid metabolism. Rev Endocr Metab Disord. 2019; 20: 461-72.

[23] Wang K, Yu X, Li Y, Guo Y, Ge L, Pu F, et al. Bifidobacterium bifidum TMC3115 Can Characteristically Influence Glucose and Lipid Profile and Intestinal Microbiota in the Middle—Aged and Elderly. Probiotics Antimicrob Proteins. 2019; 11: 1182-94.

[24] Zarezadeh M, Musazadeh V, Faghfouri AH, Roshanravan N, Dehghan P. Probiotics act as a potent intervention in improving lipid profile: An umbrella systematic review and meta—analysis. Crit Rev Food Sci Nutr. 2023; 63: 145-58.

[25] Candelli M, Franza L, Pignataro G, Ojetti V, Covino M, Piccioni A, et al. Interaction between Lipopolysaccharide and Gut Microbiota in Inflammatory Bowel Diseases. Int J Mol Sci. 2021; 22: 6242.

[26] Saltzman ET, Palacios T, Thomsen M, Vitetta L. Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non—alcoholic Fatty Liver Disease. Front Microbiol. 2018; 9: 61.

[27] Çakirlar FK. Microbiota and Metabolic Syndrome. In: Metabolic Syndrome: A Comprehensive Update with New Insights. Bentham Science Publishers; 2025. pp. 295-327.

[28] Han H, Yi B, Zhong R, Wang M, Zhang S, Ma J, et al. From gut microbiota to host appetite: gut microbiota—derived metabolites as key regulators. Microbiome. 2021; 9: 162.

[29] Smitka K, Prochazkova P, Roubalova R, Dvorak J, Papezova H, Hill M, et al. Current Aspects of the Role of Autoantibodies Directed Against Appetite—Regulating Hormones and the Gut Microbiome in Eating Disorders. Front Endocrinol (Lausanne). 2021; 12: 613983.

[30] Koh A, De Vadder F, Kovatcheva—Datchary P, Bäckhed F. From Dietary Fiber to Host Physiology: Short—Chain Fatty Acids as Key Bacterial Metabolites. Cell. 2016; 165: 1332—45.

[31] Portincasa P, Bonfrate L, Vacca M, De Angelis M, Farella I, Lanza E, et al. Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis. Int J Mol Sci. 2022; 23: 1105.

[32] Chávez—Talavera O, Tailleux A, Lefebvre P, Staels B. Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease. Gastroenterology. 2017; 152: 1679-94.e3.

[33] Ramírez—Pérez O, Cruz—Ramón V, Chinchilla—López P, Méndez—Sánchez N. The Role of the Gut Microbiota in Bile Acid Metabolism. Ann Hepatol. 2017; 16: s15-20.

[34] Aron—Wisnewsky J, Warmbrunn MV, Nieuwdorp M, Clément K. Metabolism and Metabolic Disorders and the Microbiome: The Intestinal Microbiota Associated With Obesity, Lipid Metabolism, and Metabolic Health—Pathophysiology and Therapeutic Strategies. Gastroenterology. 2021; 160: 573-99.

[35] Vallianou N, Stratigou T, Christodoulatos GS, Dalamaga M. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity—Associated Metabolic Disorders: Current Evidence and Perspectives. Curr Obes Rep. 2019; 8: 317-32.

[36] Hayyat FS, Allayie SA, Malik JA, Dar SA. The Role of Dietary Fiber in Promoting Health: A Review of Choice and Outcomes. In: Malik JA, Goyal MR, Kumari A, editors. Food Process Engineering and Technology. Singapore: Springer; 2024. pp. 493-508.

[37] Obayomi OV, Olaniran AF, Owa SO. Unveiling the role of functional foods with emphasis on prebiotics and probiotics in human health: A review. J Funct Foods. 2024; 119: 106337.

[38] Saidaiah P, Banu Z, Khan AA, Geetha A, Somraj B. A comprehensive review of Omega—3 fatty acids: Sources, industrial applications, and health benefits. Ann Phytomedicine. 2024; 13: 209-25.

[39] Miclotte L, Van de Wiele T. Food processing, gut microbiota and the globesity problem. Crit Rev Food Sci Nutr. 2020; 60: 1769-82.

[40] Hever J, Cronise RJ. Plant—based nutrition for healthcare professionals: implementing diet as a primary modality in the prevention and treatment of chronic disease. J Geriatr Cardiol. 2017; 14: 355-68.

[41] Sharma A, Yadav BS, Ritika. Resistant starch: physiological roles and food applications. Food Rev Int. 2008; 24: 193-234.

[42] Ahajumobi NE. Nutrients, Vitamins, Mineral and Hydration for Health Restoration. iUniverse; 2022.

[43] Stengler M. The Holistic Guide to Gut Health: Discover the Truth About Leaky Gut, Balancing Your Microbiome, and Restoring Whole—Body Health. Hay House, Inc; 2024.

[44] Mirhosseini SM, Mahdavi A, Yarmohammadi H, Razavi A, Rezaei M, Soltanipur M, et al. What is the link between the dietary inflammatory index and the gut microbiome? A systematic review. Eur J Nutr. 2024; 63: 2407—19.

[45] Zheng Y, Hou J, Guo S, Song J. The association between the dietary index for gut microbiota and metabolic dysfunction—associated fatty liver disease: a cross—sectional study. Diabetol Metab Syndr. 2025; 17: 17.

[46] Zheng J, Hoffman KL, Chen JS, Shivappa N, Sood A, Browman GJ, et al. Dietary inflammatory potential in relation to the gut microbiome: results from a cross—sectional study. Br J Nutr. 2020; 124: 931—42.

[47] Lozano CP, Wilkens LR, Shvetsov YB, Maskarinec G, Park SY, Shepherd JA, et al. Associations of the Dietary Inflammatory Index with total adiposity and ectopic fat through the gut microbiota, LPS, and C—reactive protein in the Multiethnic Cohort—Adiposity Phenotype Study. Am J Clin Nutr. 2022; 115: 1344—56.

[48] Tannock GW, Liu Y. Guided dietary fibre intake as a means of directing short—chain fatty acid production by the gut microbiota. J R Soc New Zeal. 2019; 50: 434-55.

[49] Vinelli V, Biscotti P, Martini D, Del Bo’ C, Marino M, Meroño T, et al. Effects of Dietary Fibers on Short—Chain Fatty Acids and Gut Microbiota Composition in Healthy Adults: A Systematic Review. Nutrients. 2022; 14: 2559.

[50] Fernández J, Redondo—Blanco S, Gutiérrez—del—Río I, Miguélez EM, Villar CJ, Lombo F. Colon microbiota fermentation of dietary prebiotics towards short—chain fatty acids and their roles as anti—inflammatory and antitumour agents: A review. J Funct Foods. 2016; 25: 511-22.

[51] Peredo—Lovillo A, Romero—Luna HE, Jiménez—Fernández M. Health promoting microbial metabolites produced by gut microbiota after prebiotics metabolism. Food Res Int. 2020; 136: 109473.

[52] Beena Divya J, Kulangara Varsha K, Madhavan Nampoothiri K, Ismail B, Pandey A. Probiotic fermented foods for health benefits. Eng Life Sci. 2012; 12: 377-90.

[53] Parvez S, Malik KA, Ah Kang S, Kim HY. Probiotics and their fermented food products are beneficial for health. J Appl Microbiol. 2006; 100: 1171—85.

[54] Dimidi E, Cox SR, Rossi M, Whelan K. Fermented Foods: Definitions and Characteristics, Impact on the Gut Microbiota and Effects on Gastrointestinal Health and Disease. Nutrients. 2019; 11: 1806.

[55] Dahiya D, Nigam PS. Probiotics, prebiotics, synbiotics, and fermented foods as potential biotics in nutrition improving health via microbiome—gut—brain axis. Fermentation. 2022; 8: 303.

[56] Wang X, Qi Y, Zheng H. Dietary Polyphenol, Gut Microbiota, and Health Benefits. Antioxidants (Basel). 2022; 11: 1212.

[57] Barbalho SM, Goulart Rde A, Quesada K, Bechara MD, de Carvalho Ade C. Inflammatory bowel disease: can omega—3 fatty acids really help? Ann Gastroenterol. 2016; 29: 37-43.

[58] Garcia K, Ferreira G, Reis F, Viana S. Impact of dietary sugars on gut microbiota and metabolic health. Diabetology. 2022; 3: 549-60.

[59] Zhao J, Zhang X, Liu H, Brown MA, Qiao S. Dietary Protein and Gut Microbiota Composition and Function. Curr Protein Pept Sci. 2019; 20: 145—54.

[60] Ma N, Tian Y, Wu Y, Ma X. Contributions of the Interaction Between Dietary Protein and Gut Microbiota to Intestinal Health. Curr Protein Pept Sci. 2017; 18: 795-808.

[61] Bulsiewicz W. Fiber fueled: the plant—based gut health program for losing weight, restoring your health, and optimizing your microbiome. Penguin; 2020.

[62] Daniel IK, Njue OM, Sanad YM. Antimicrobial Effects of Plant—Based Supplements on Gut Microbial Diversity in Small Ruminants. Pathogens. 2023; 13: 31.

[63] Regassa A, Nyachoti CM. Application of resistant starch in swine and poultry diets with particular reference to gut health and function. Anim Nutr. 2018; 4: 305—10.

[64] Keenan MJ, Zhou J, Hegsted M, Pelkman C, Durham HA, Coulon DB, et al. Role of resistant starch in improving gut health, adiposity, and insulin resistance. Adv Nutr. 2015; 6: 198-205.

[65] Mach N, Fuster—Botella D. Endurance exercise and gut microbiota: A review. J Sport Health Sci. 2017; 6: 179-97.

[66] Zhang L, Zhang Z, Xu L, Zhang X. Maintaining the Balance of Intestinal Flora through the Diet: Effective Prevention of Illness. Foods. 2021; 10: 2312.

[67] Bishehsari F, Magno E, Swanson G, Desai V, Voigt RM, Forsyth CB, et al. Alcohol and Gut—Derived Inflammation. Alcohol Res. 2017; 38: 163-71.

[68] Bajaj JS. Alcohol, liver disease and the gut microbiota. Nat Rev Gastroenterol Hepatol. 2019; 16: 235-46.

[69] Hills RD Jr, Pontefract BA, Mishcon HR, Black CA, Sutton SC, Theberge CR. Gut Microbiome: Profound Implications for Diet and Disease. Nutrients. 2019; 11: 1613.

[70] Ross FC, Patangia D, Grimaud G, Lavelle A, Dempsey EM, Ross RP, et al. The interplay between diet and the gut microbiome: implications for health and disease. Nat Rev Microbiol. 2024; 22: 671-86.

[71] Cooney OD, Nagareddy PR, Murphy AJ, Lee MKS. Healthy Gut, Healthy Bones: Targeting the Gut Microbiome to Promote Bone Health. Front Endocrinol (Lausanne). 2021; 11: 620466.

[72] Skinner E. The Bone Broth Miracle Diet: Lose Weight, Feel Great, and Revitalize Your Health in Just 21 Days. Simon and Schuster; 2017.

[73] Aleixandre A, Miguel M. Dietary fiber in the prevention and treatment of metabolic syndrome: a review. Crit Rev Food Sci Nutr. 2008; 48: 905—12.

[74] Deehan EC, Mocanu V, Madsen KL. Effects of dietary fibre on metabolic health and obesity. Nat Rev Gastroenterol Hepatol. 2024; 21: 301—18.

[75] Chan M, Larsen N, Baxter H, Jespersen L, Ekinci EI, Howell K. The impact of botanical fermented foods on metabolic syndrome and type 2 diabetes: a systematic review of randomised controlled trials. Nutr Res Rev. 2024; 37: 396-415.

[76] Şanlier N, Gökcen BB, Sezgin AC. Health benefits of fermented foods. Crit Rev Food Sci Nutr. 2019; 59: 506-27.

[77] Kim MJ, Kim JI, Ryu CH, Kang MJ. Effects of Fermented Beverage in Subjects with Metabolic Syndrome. Prev Nutr Food Sci. 2021; 26: 12-20.

[78] Martínez Steele E, Juul F, Neri D, Rauber F, Monteiro CA. Dietary share of ultra—processed foods and metabolic syndrome in the US adult population. Prev Med. 2019; 125: 40-8.

[79] Shu L, Zhang X, Zhou J, Zhu Q, Si C. Ultra—processed food consumption and increased risk of metabolic syndrome: a systematic review and meta—analysis of observational studies. Front Nutr. 2023; 10: 1211797.

[80] Ristic—Medic D, Vucic V. Dietary fats and metabolic syndrome. J Nutr Heal Food Sci. 2013; 1: 8.

[81] Tenorio—Jiménez C, Martínez—Ramírez MJ, Gil Á, Gómez—Llorente C. Effects of Probiotics on Metabolic Syndrome: A Systematic Review of Randomized Clinical Trials. Nutrients. 2020; 12: 124.

[82] Cani PD, Van Hul M. Novel opportunities for next—generation probiotics targeting metabolic syndrome. Curr Opin Biotechnol. 2015; 32: 21-7.

[83] He M, Shi B. Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics. Cell Biosci. 2017; 7: 54.

[84] Srivastava S, Kumar V, Kapil L, Prasad S, Kritika, Khan S, et al. Functional Foods and Spices in the Management of Metabolic Syndrome. In: Nutraceuticals in Obesity Management and Control. 1st Edition. Apple Academic Press; 2025. pp. 211-83.

[85] Jael Teresa de Jesús QV, Gálvez—Ruíz JC, Márquez Ibarra AA, Leyva—Peralta MA. Perspectives on Berberine and the Regulation of Gut Microbiota: As an Anti—Inflammatory Agent. Pharmaceuticals (Basel). 2025; 18: 193.

[86] Shehzad A, Ha T, Subhan F, Lee YS. New mechanisms and the anti—inflammatory role of curcumin in obesity and obesity—related metabolic diseases. Eur J Nutr. 2011; 50: 151-61.

[87] Innes JK, Calder PC. Marine omega—3 (N—3) fatty acids for cardiovascular health: an update for 2020. Int J Mol Sci. 2020; 21: 1362.

[88] Anderson RA, Zhan Z, Luo R, Guo X, Guo Q, Zhou J, et al. Cinnamon extract lowers glucose, insulin and cholesterol in people with elevated serum glucose. J Tradit Complement Med. 2015; 6: 332-6.

[89] Havel PJ. A scientific review: the role of chromium in insulin resistance. Diabetes Educ. 2004; Suppl: 2-14.

[90] Feng J, Wang H, Jing Z, Wang Y, Cheng Y, Wang W, et al. Role of Magnesium in Type 2 Diabetes Mellitus. Biol Trace Elem Res. 2020; 196: 74-85.

[91] Zozina VI, Covantev S, Goroshko OA, Krasnykh LM, Kukes VG. Coenzyme Q10 in Cardiovascular and Metabolic Diseases: Current State of the Problem. Curr Cardiol Rev. 2018; 14: 164-74.

[92] Ulanski T, Cirulli M, Virmani MA. The role of L—carnitine in kidney disease and related metabolic dysfunctions. Kidney Dial. 2023; 3: 178-91.

[93] Kang DH, Jung EY, Chang UJ, Bae SH, Suh HJ. Psyllium husk combined with hydroxycitrate reduces body weight gain and body fat in diet—induced obese rats. Nutr Res. 2007; 27: 349—55.

[94] Jang HJ, Ridgeway SD, Kim JA. Effects of the green tea polyphenol epigallocatechin—3—gallate on high—fat diet—induced insulin resistance and endothelial dysfunction. Am J Physiol Endocrinol Metab. 2013; 305: E1444—51.

[95] Parsamanesh N, Asghari A, Sardari S, Tasbandi A, Jamialahmadi T, Xu S, et al. Resveratrol and endothelial function: A literature review. Pharmacol Res. 2021; 170: 105725.

[96] Ried K, Fakler P. Potential of garlic (Allium sativum) in lowering high blood pressure: mechanisms of action and clinical relevance. Integr Blood Press Control. 2014; 7: 71-82.

[97] Winston D, Maimes S. Adaptogens: herbs for strength, stamina, and stress relief. Simon and Schuster; 2019.

[98] Egea MB, Oliveira Filho JG, Lemes AC. Investigating the Efficacy of Saccharomyces boulardii in Metabolic Syndrome Treatment: A Narrative Review of What Is Known So Far. Int J Mol Sci. 2023; 24: 12015.

[99] Cristofori F, Dargenio VN, Dargenio C, Miniello VL, Barone M, Francavilla R. Anti—Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body. Front Immunol. 2021; 12: 578386.

[100] Jantzi S. The Effects of Saccharomyces Cerevisiae Boulardii CNCM I—1079 Supplementation on Gut Barrier Function and Systemic Inflammation in Transition Dairy Cows [dissertation]. University of Guelph; 2024.

[101] Kothari D, Patel S, Kim SK. Probiotic supplements might not be universally—effective and safe: A review. Biomed Pharmacother. 2019; 111: 537-47.

[102] Yang W, Si SC, Wang WH, Li J, Ma YX, Zhao H, et al. Gut dysbiosis in primary sarcopenia: potential mechanisms and implications for novel microbiome—based therapeutic strategies. Front Microbiol. 2025; 16: 1526764.

[103] Dugoua JJ, Machado M, Zhu X, Chen X, Koren G, Einarson TR. Probiotic safety in pregnancy: a systematic review and meta—analysis of randomized controlled trials of Lactobacillus, Bifidobacterium, and Saccharomyces spp. J Obstet Gynaecol Can. 2009; 31: 542—52.

[104] Igbafe J, Kilonzo—Nthenge A, Nahashon SN, Mafiz AI, Nzomo M. Probiotics and antimicrobial effect of Lactiplantibacillus plantarum, Saccharomyces cerevisiae, and Bifidobacterium longum against common foodborne pathogens in poultry. Agriculture. 2020; 10: 368.

[105] Yang F, Zhu WJ, Edirisuriya P, Ai Q, Nie K, Ji XM, et al. Beneficial effects of a combination of Clostridium cochlearium and Lactobacillus acidophilus on body weight gain, insulin sensitivity, and gut microbiota in high—fat diet—induced obese mice. Nutrition. 2022; 93: 111439.

[106] Pirillo A, Catapano AL. Berberine, a plant alkaloid with lipid— and glucose—lowering properties: From in vitro evidence to clinical studies. Atherosclerosis. 2015; 243: 449-61.

[107] Xu X, Yi H, Wu J, Kuang T, Zhang J, Li Q, et al. Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence. Biomed Pharmacother. 2021; 133: 110984.

[108] Shao W, Yu Z, Chiang Y, Yang Y, Chai T, Foltz W, et al. Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes. PLoS One. 2012; 7: e28784.

[109] Navekar R, Rafraf M, Ghaffari A, Asghari—Jafarabadi M, Khoshbaten M. Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver Diseases. J Am Coll Nutr. 2017; 36: 261-7.

[110] Ellulu MS, Khaza’ai H, Abed Y, Rahmat A, Ismail P, Ranneh Y. Role of fish oil in human health and possible mechanism to reduce the inflammation. Inflammopharmacology. 2015; 23: 79-89.

[111] Santos HO, Price JC, Bueno AA. Beyond Fish Oil Supplementation: The Effects of Alternative Plant Sources of Omega—3 Polyunsaturated Fatty Acids upon Lipid Indexes and Cardiometabolic Biomarkers—An Overview. Nutrients. 2020; 12: 3159.

[112] Najafi N, Mehri S, Ghasemzadeh Rahbardar M, Hosseinzadeh H. Effects of alpha lipoic acid on metabolic syndrome: A comprehensive review. Phytother Res. 2022; 36: 2300-23.

[113] Tangvarasittichai S, Sanguanwong S, Sengsuk C, Tangvarasittichai O. Effect of cinnamon supplementation on oxidative stress, inflammation and insulin resistance in patients with type 2 diabetes mellitus. Int J Toxicol Pharmacol Res. 2015; 7.

[114] Mollazadeh H, Hosseinzadeh H. Cinnamon effects on metabolic syndrome: a review based on its mechanisms. Iran J Basic Med Sci. 2016; 19: 1258-70.

[115] Shang C, Lin H, Fang X, Wang Y, Jiang Z, Qu Y, et al. Beneficial effects of cinnamon and its extracts in the management of cardiovascular diseases and diabetes. Food Funct. 2021; 12: 12194—220.

[116] Zhao F, Pan D, Wang N, Xia H, Zhang H, Wang S, et al. Effect of Chromium Supplementation on Blood Glucose and Lipid Levels in Patients with Type 2 Diabetes Mellitus: a Systematic Review and Meta—analysis. Biol Trace Elem Res. 2022; 200: 516-25.

[117] Cloyd J. The top 6 essential health benefits of magnesium that you should know. Nutrition. 2023.

[118] Fatima G, Dzupina A, B Alhmadi H, Magomedova A, Siddiqui Z, Mehdi A, et al. Magnesium Matters: A Comprehensive Review of Its Vital Role in Health and Diseases. Cureus. 2024; 16: e71392.

[119] Gutierrez—Mariscal FM, Arenas—de Larriva AP, Limia—Perez L, Romero—Cabrera JL, Yubero—Serrano EM, López—Miranda J. Coenzyme Q₁₀ Supplementation for the Reduction of Oxidative Stress: Clinical Implications in the Treatment of Chronic Diseases. Int J Mol Sci. 2020; 21: 7870.

[120] Ochoa JJ, Quiles JL, Huertas JR, Mataix J. Coenzyme Q10 protects from aging—related oxidative stress and improves mitochondrial function in heart of rats fed a polyunsaturated fatty acid (PUFA)—rich diet. J Gerontol A Biol Sci Med Sci. 2005; 60: 970—5.

[121] Garbossa SG, Folli F. Vitamin D, sub—inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism. Rev Endocr Metab Disord. 2017; 18: 243-58.

[122] Szymczak—Pajor I, Drzewoski J, Śliwińska A. The Molecular Mechanisms by Which Vitamin D Prevents Insulin Resistance and Associated Disorders. Int J Mol Sci. 2020; 21: 6644.

[123] Prakash N, Ghosal S, Maity M. A Review on Therapeutic Effects of L—Carnitine: An Update. J Adv Zool. 2023; 44.

[124] Pokushalov E, Ponomarenko A, Garcia C, Pak I, Shrainer E, Seryakova M, et al. The Impact of Glucomannan, Inulin, and Psyllium Supplementation (Soloways^TM) on Weight Loss in Adults with FTO, LEP, LEPR, and MC4R Polymorphisms: A Randomized, Double—Blind, Placebo—Controlled Trial. Nutrients. 2024; 16: 557.

[125] Gamage HKAH, Tetu SG, Chong RWW, Bucio—Noble D, Rosewarne CP, Kautto L, et al. Fiber Supplements Derived From Sugarcane Stem, Wheat Dextrin and Psyllium Husk Have Different In Vitro Effects on the Human Gut Microbiota. Front Microbiol. 2018; 9: 1618.

[126] Most J, Timmers S, Warnke I, Jocken JWE, van Boekschoten M, de Groot P, et al. Combined epigallocatechin—3—gallate and resveratrol supplementation for 12 wk increases mitochondrial capacity and fat oxidation, but not insulin sensitivity, in obese humans: a randomized controlled trial. Am J Clin Nutr. 2016; 104: 215-27.

[127] Kapoor MP, Sugita M, Fukuzawa Y, Okubo T. Physiological effects of epigallocatechin—3—gallate (EGCG) on energy expenditure for prospective fat oxidation in humans: A systematic review and meta—analysis. J Nutr Biochem. 2017; 43: 1-10.

[128] Castaldo L, Narváez A, Izzo L, Graziani G, Gaspari A, Minno GD, et al. Red Wine Consumption and Cardiovascular Health. Molecules. 2019; 24: 3626.

[129] Barber TM, Kabisch S, Randeva HS, Pfeiffer AFH, Weickert MO. Implications of Resveratrol in Obesity and Insulin Resistance: A State—of—the—Art Review. Nutrients. 2022; 14: 2870.

[130] Salehi B, Zucca P, Orhan IE, Azzini E, Adetunji CO, Mohammed SA, et al. Allicin and health: A comprehensive review. Trends Food Sci Technol. 2019; 86: 502—16.

[131] Piragine E, Citi V, Lawson K, Calderone V, Martelli A. Regulation of blood pressure by natural sulfur compounds: Focus on their mechanisms of action. Biochem Pharmacol. 2022; 206: 115302.

[132] Quinones D, Barrow M, Seidler K. Investigating the Impact of Ashwagandha and Meditation on Stress Induced Obesogenic Eating Behaviours. J Am Nutr Assoc. 2025; 44: 68-88.

[133] Rakha A, Ramzan Z, Umar N, Rasheed H, Fatima A, Ahmed Z, et al. The Role of Ashwagandha in Metabolic Syndrome: A Review of Traditional Knowledge and Recent Research Findings. J Biol Regul Homeost. Agents. 2023; 37: 5091-103.

[134] Yoo JY, Kim SS. Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders. Nutrients. 2016; 8: 173.

[135] Jang H, Park K. Omega—3 and omega—6 polyunsaturated fatty acids and metabolic syndrome: A systematic review and meta—analysis. Clin Nutr. 2020; 39: 765-73.

[136] Chiva—Blanch G, Badimon L. Effects of Polyphenol Intake on Metabolic Syndrome: Current Evidences from Human Trials. Oxid Med Cell Longev. 2017; 2017: 5812401.

[137] Och A, Och M, Nowak R, Podgórska D, Podgórski R. Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the Disease. Molecules. 2022; 27: 1351.

[138] Tabeshpour J, Imenshahidi M, Hosseinzadeh H. A review of the effects of Berberis vulgaris and its major component, berberine, in metabolic syndrome. Iran J Basic Med Sci. 2017; 20: 557-68.